A triumph for injectable PrEP, but a sobering result for oral PrEP
Women taking long-acting injections of cabotegravir had 89% fewer HIV infections than women prescribed daily PrEP pills in a landmark study conducted in seven African countries, Dr Sinead Delany-Moretlwe of the University of Witwatersrand told the virtual HIV Research for Prevention conference today. As conference co-chair Professor Sheena McCormack commented, the results are a triumph… Read More »